These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The management of diabetes. Installment 6: Further considerations in the use of the sulfonylureas and phenformin. Am Fam Physician GP; 1970 Oct; 2(4):113-27. PubMed ID: 5273255 [No Abstract] [Full Text] [Related]
6. [25 years of diabetic treatment by oral hypoglycemic agents: successes and failures]. Tattersall RB Journ Annu Diabetol Hotel Dieu; 1984; ():183-91. PubMed ID: 6443219 [No Abstract] [Full Text] [Related]
7. [Our experience with Daonil. A new oral hypoglycemic agent]. Rodriguez-Miñon JL; Arrieta F; Herrera JL Diabete; 1970; 18(3):164-5. PubMed ID: 5472233 [No Abstract] [Full Text] [Related]
8. Treatment of diabetes with oral hypoglycemic drugs. Moss JM; DeLawter DE GP; 1966 Oct; 34(4):85-8. PubMed ID: 5912533 [No Abstract] [Full Text] [Related]
10. [Clinico-therapeutic observations on the use of a new oral hypoglycemic drug (HB 419-297 R)]. Calì V; Sgroi C Clin Ter; 1974 Jun; 69(6):535-48. PubMed ID: 4210876 [No Abstract] [Full Text] [Related]
11. [Glibenclamide-phenformin combination in the treatment of diabetes in adults]. Pittera A; Ruvolo F; Di Blasi F Clin Ter; 1975 Aug; 74(3):231-58. PubMed ID: 819201 [No Abstract] [Full Text] [Related]
12. [Action of instantaneous-delayed action phenformin, alone or in combined therapy, in 50 hospitalized diabetics]. Vague J; Vague P; Jaquet P; Gerolami G Mars Med; 1966; 103(4):331-3. PubMed ID: 5997802 [No Abstract] [Full Text] [Related]
13. [Clinical experimentation with a new oral antidiabetic]. Palmas S; Onorato D; Baule GM Clin Ter; 1972 Nov; 63(4):337-58. PubMed ID: 4630027 [No Abstract] [Full Text] [Related]
14. Experience with phenylethylbiguanide (DBI) tablets and timed-disintegration capsules (DBI-TD) administered as an adjunct to insulin or sulfonylurea drugs in previously treated diabetic patients. Jakobson T; Kahanpää A; Berglund B Ann Med Intern Fenn; 1965; 54(3):109-16. PubMed ID: 5854020 [No Abstract] [Full Text] [Related]
15. Oral hypoglycemic agents. Med Lett Drugs Ther; 1970 Jan; 11(2):5-7. PubMed ID: 5421186 [No Abstract] [Full Text] [Related]
16. [Controlled clinical study of a new oral antidiabetic formed by a glibenclamide-phenformin association]. Torri A; Zanni A Clin Ter; 1974 Aug; 70(3):236-57. PubMed ID: 4214456 [No Abstract] [Full Text] [Related]
17. A clinical trial of glybenclamide (HB-419): a new oral hypoglycemic agent. Choudhry AS; Gomez E; McKendry JB Appl Ther; 1970 May; 12(5):28-9. PubMed ID: 4912481 [No Abstract] [Full Text] [Related]
18. [Clinical testing of a sulfonylurea preparation (glibenclamide)]. Sigroth K; Steen B; Svanborg A Lakartidningen; 1969 Nov; 66(45):4647-50. PubMed ID: 4996889 [No Abstract] [Full Text] [Related]
19. [Glybenclamide and its place among sulfanylureas in the treatment of diabetes mellitus]. Cabezas Cerrato J; Fernández-Cruz A; Fernández-Cruz A Rev Clin Esp; 1970 May; 117(4):375-86. PubMed ID: 5471527 [No Abstract] [Full Text] [Related]
20. Tolinase--a new oral antidiabetic drug. Med Lett Drugs Ther; 1966 Sep; 8(19):77-8. PubMed ID: 5971398 [No Abstract] [Full Text] [Related] [Next] [New Search]